176 related articles for article (PubMed ID: 36555091)
1. Klotho Protein Decreases MMP-Mediated Degradation of Contractile Proteins during Ischaemia/Reperfusion Injury to the Cardiomyocytes.
Olejnik A; Krzywonos-Zawadzka A; Banaszkiewicz M; Bil-Lula I
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555091
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating Effect of Klotho Protein on Rat Heart during I/R Injury.
Olejnik A; Krzywonos-Zawadzka A; Banaszkiewicz M; Bil-Lula I
Oxid Med Cell Longev; 2020; 2020():6427284. PubMed ID: 33123314
[TBL] [Abstract][Full Text] [Related]
3. The Klotho protein supports redox balance and metabolic functions of cardiomyocytes during ischemia/reperfusion injury.
Olejnik A; Banaszkiewicz M; Krzywonos-Zawadzka A; Bil-Lula I
Cardiol J; 2022; 29(5):836-849. PubMed ID: 34967938
[TBL] [Abstract][Full Text] [Related]
4. Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury.
Olejnik A; Krzywonos-Zawadzka A; Banaszkiewicz M; Bil-Lula I
J Cell Mol Med; 2020 Jun; 24(11):6448-6458. PubMed ID: 32319182
[TBL] [Abstract][Full Text] [Related]
5. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.
Polewicz D; Cadete VJ; Doroszko A; Hunter BE; Sawicka J; Szczesna-Cordary D; Light PE; Sawicki G
J Cell Mol Med; 2011 May; 15(5):1136-47. PubMed ID: 20518849
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury.
Krzywonos-Zawadzka A; Franczak A; Olejnik A; Radomski M; Gilmer JF; Sawicki G; Woźniak M; Bil-Lula I
J Cell Mol Med; 2019 Apr; 23(4):2836-2848. PubMed ID: 30729745
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury.
Lin HB; Cadete VJ; Sra B; Sawicka J; Chen Z; Bekar LK; Cayabyab F; Sawicki G
Biomed Res Int; 2014; 2014():810371. PubMed ID: 25147815
[TBL] [Abstract][Full Text] [Related]
8. High-intensity interval training increases myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury.
Ramez M; Ramezani F; Nasirinezhad F; Rajabi H
Exp Physiol; 2020 Apr; 105(4):652-665. PubMed ID: 32052504
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of inhibitors of MMPs and ROS-dependent modifications of contractile proteins on protection hearts subjected to oxidative stress.
Sawicki G
Curr Pharm Des; 2014; 20(9):1345-8. PubMed ID: 23978100
[TBL] [Abstract][Full Text] [Related]
10. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
Gao L; Zheng YJ; Gu SS; Tan JL; Paul C; Wang YG; Yang HT
J Mol Cell Cardiol; 2014 Dec; 77():102-12. PubMed ID: 25451385
[TBL] [Abstract][Full Text] [Related]
11. Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart.
Cadete VJ; Sawicka J; Bekar LK; Sawicki G
Br J Pharmacol; 2013 Sep; 170(2):380-90. PubMed ID: 23822644
[TBL] [Abstract][Full Text] [Related]
12. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.
Ali MA; Cho WJ; Hudson B; Kassiri Z; Granzier H; Schulz R
Circulation; 2010 Nov; 122(20):2039-47. PubMed ID: 21041693
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.
Castro MM; Fuah J; Ali M; Sung M; Schulz J; Kondo MY; Fan X; Holt A; Schulz R
Biochem Pharmacol; 2013 Aug; 86(4):469-75. PubMed ID: 23774623
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with nebivolol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischaemia-reperfusion injury.
Ersan S; Tanrısev M; Cavdar Z; Celık A; Unlu M; Kocak A; Kose T
Nephrology (Carlton); 2017 Dec; 22(12):1023-1029. PubMed ID: 28118507
[TBL] [Abstract][Full Text] [Related]
15. Silencing RNA for MMPs May Be Utilized for Cardioprotection.
Banaszkiewicz M; Krzywonos-Zawadzka A; Olejnik A; Noszczyk-Nowak A; Bil-Lula I
Cardiovasc Ther; 2022; 2022():9729018. PubMed ID: 36082193
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury.
Bil-Lula I; Lin HB; Biały D; Wawrzyńska M; Diebel L; Sawicka J; Woźniak M; Sawicki G
J Cell Mol Med; 2016 Jun; 20(6):1086-94. PubMed ID: 26992120
[TBL] [Abstract][Full Text] [Related]
17. Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2.
Cadete VJ; Sawicka J; Jaswal JS; Lopaschuk GD; Schulz R; Szczesna-Cordary D; Sawicki G
FEBS J; 2012 Jul; 279(13):2444-54. PubMed ID: 22564771
[TBL] [Abstract][Full Text] [Related]
18. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.
Roczkowsky A; Chan BYH; Lee TYT; Mahmud Z; Hartley B; Julien O; Armanious G; Young HS; Schulz R
Cardiovasc Res; 2020 Apr; 116(5):1021-1031. PubMed ID: 31373602
[TBL] [Abstract][Full Text] [Related]
19. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Lee TYT; Mahmud Z; Schulz R
Basic Res Cardiol; 2019 Sep; 114(6):42. PubMed ID: 31506724
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MMP-2 expression affects metabolic enzyme expression levels: proteomic analysis of rat cardiomyocytes.
Lin HB; Sharma K; Bialy D; Wawrzynska M; Purves R; Cayabyab FS; Wozniak M; Sawicki G
J Proteomics; 2014 Jun; 106():74-85. PubMed ID: 24769238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
